期刊文献+

探讨Ⅳ型遗传性血色病肝脏hepcidin mRNA表达及意义 被引量:4

To investigate the significance of the expression of hepcidin mRNA in liver tissues of hereditary hemochromatosis type Ⅳ
下载PDF
导出
摘要 目的探讨Ⅳ型遗传性血色病肝脏hepcidin mRNA表达及临床意义。方法对一例遗传性血色病先证者的家系进行遗传学问询,病史采集,体格检查,实验室检查,MRI检查及肝脏组织病理学检查,运用实时荧光定量PCR法检测肝脏hepcidin mRNA表达,并进行遗传性血色病发病相关基因的基因筛查。结果该家系15人有7例经MRI证实存在不同程度实质脏器铁沉积,3例接受肝活检者中的2例肝脏组织普鲁士蓝染色证实铁沉积,实时荧光定量PCR法检测显示肝脏hepcidin mRNA表达上调,外周静脉血基因筛查发现2q32的SLC40A1六号外显子有一处碱基发生点突变,即T173C。结论1.本家系罹患Ⅳ型遗传性血色病,遗传学特征为常染色体显性遗传,SLC40A1六号外显子有一处点突变,但该突变与国际上先前报道的突变位点并不相符,说明该基因突变可能是新的突变类型;2.本家系肝脏hepcidin mRNA表达上调,提示血清hepcidin水平升高,说明可能存在hepcidin抵抗现象,使机体对hepcidin负性调节低反应,从而导致铁代谢紊乱出现铁沉积并出现脏器功能损害。 Objective To investigate the expression of hepcidin mRNA in liver tissues of hereditary hemochromatosis type Ⅳ and explore its clinical significance and possible pathogenesis. Methods The family tree of one case of the proband had been studied by inquiring genetically, history collection, physical examination, lab examination ( such as the blood routine, liver of function, serum iron, ferritin test and fasting blood - glucose) as well as the MRI check of the material organs, examination of hepatic pathology and staining by Prussian blue, the expression of hepcidin mRNA was detected in liver tissue by qRT- PCR, and also the gene related to mutation genes of hemochromatosis of the peripheral venous blood was screened. Results 7 cases of 15 family tree members had been checked as that there is visceral organs iron deposit differently, 2 cases of 3 patients been having liver tissue biopsy had been detected iron deposit in liver tissue by staining with Prussian blue. The expression of liver hepcidin mRNA of the 3 patients indicated moving - up by qRT - PCR. A point mu- tation on one base of the sixth extron of SLC40A1 of 2q32 had been detected by gene screening of the peripheral venous blood, i.e. the base of T173C. Conclusions 1. The family tree members are suffering the hereditary hemochromatosis type Ⅳ, and the hereditary character is autosome dominant hereditary, the point mutation is on the sixth extron of SLC40A1, but this point of mutation is different from those reports published internationally, therefore this gene mutation may be considered as the new type mutation ; 2. The expression of liver hepcidin mRNA of the 3 cases of the family tree members is indicated moving - up, so they occured hepcidin resistance that unable to respond to hepcidin show iron overload.
出处 《临床肝胆病杂志》 CAS 2008年第6期436-439,共4页 Journal of Clinical Hepatology
关键词 Ⅳ型遗传性血色病 HEPCIDIN 实时荧光定量PCR hereditary hemochromatosis type Ⅳ hepcidin qRT - PCR
  • 相关文献

参考文献10

  • 1Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, et al. Geography of HFE C282Y and H63D mutation[ J]. Genet Test, 2000, 4:183 -98.
  • 2Deicher R, Horl WH. New insights into the regulation of iron homeostasis[ J ]. Eur J Cli Investigation, 2006, 36:301 - 309.
  • 3付丽娟,段相林,钱忠明,常彦忠.铁代谢与铁调素hepcidin[J].生理科学进展,2005,36(3):233-236. 被引量:22
  • 4Massimo F. Hereditary Iron Overload: Update on Pathophysiology, Diagnosis, and Treatment[ J]. Am J Hematology, 2006, 81:202 - 209.
  • 5Andrews NC. Disorders of iron metabolism [ J]. N Engl J Med, 1999,341 (26): 1986 - 1995.
  • 6McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron -regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation[ J]. Mol Cell, 2000,5: 299 -309.
  • 7Donovan A, Brownlie A, Zhou H, et al. Positional cloning of zebrafish ferroportin I identifies a conserved vertebrate iron exporter[ J]. Nature, 2000,403: 776 - 781.
  • 8Wallace DF, Clark RM, Harley HAJ, et al. Autosomal dominant iron overload due to a novel mutation of ferroportinl associated with parenchymal iron loadingand cirrhosis [ J ]. J Hepatol, 2004, 40:710-713.
  • 9Elizabeta N. Ferroportin mutations: a tale of two phenotypes [ J ]. Blood, 2005, 105:3763 -3764.
  • 10Pietrangelo A. The ferroportin disease [ J ]. Blood Cells Mol Dis, 2004, 32:131 - 138.

二级参考文献10

  • 1Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett, 2000, 480 : 147 - 150.
  • 2Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem, 2001, 276 : 7806-7810.
  • 3Qian ZM, Li HY, Sun HZ, et al. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev, 2002, 54 : 561 -587.
  • 4Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood, 2003, 102 :783 -788.
  • 5Knutson M, Wessling-Resniek M. Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol, 2003,38 : 61 -88.
  • 6Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liverspecific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem, 2001, 276 : 7811 -7819.
  • 7Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. PNAS, 2001,98 : 8780- 8785.
  • 8Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues?Blood Cells Mol Dis, 2003, 30 : 288 -297.
  • 9Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. PNAS, 2001, 98 : 8160-8162.
  • 10Nemeth E, Tutfle MS, Powelson J, et al. Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science, 2004, 306 : 2090- 2093.

共引文献21

同被引文献19

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部